04:47:08 EDT Thu 28 Mar 2024
Enter Symbol
or Name
USA
CA



The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of BioAmber Inc. Investors and Encourages Investors to Contact the Firm

2017-04-13 10:30 ET - News Release


BENSALEM, Pa. -- (Business Wire)

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased BioAmber Inc. (“BioAmber” or the “Company”) (NYSE: BIOA) securities (1) pursuant and/or traceable to BioAmber’s secondary public offering on or about January 23, 2017 (the “Offering”); and/or (2) between January23, 2017 and March 16, 2017, inclusive (the “Class Period”). BioAmber investors have until May 17, 2017 to file a lead plaintiff motion.

Investors suffering losses on their BioAmber investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.

On March 16, 2017, BioAmber disclosed its financial results for the 2016 fiscal year, revealing that the Company had failed to meet its predicted revenue forecast by $1.3 million. Among other things, the Company’s President Fabrice Orecchioni blamed the disappointing results on “pricing pressures” and “a disruption from a large customer.” Following this news, BioAmber stock declined, falling almost 20%, to close at $2.55 on March 17, 2017.

Then, on March 31, 2017, the Company announced that Mario Saucier would cease serving as the Company’s Chief Financial Officer. On this news, the Company’s share price fell approximately 6% on April 1, 2017, thereby injuring investors.

According to the complaint filed in this class action, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) a large customer of BioAmber that was expected to purchase $2.8 million of succinic acid in Q4 2016 experienced a technical problem in its manufacturing facility and postponed the order to 2017; and (2) as a result, defendants’ statements about BioAmber’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

If you purchased shares of BioAmber pursuant to the Offering and/or during the Class Period you may move the Court no later than May 17, 2017 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts:

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Source: Law Offices of Howard G. Smith

© 2024 Canjex Publishing Ltd. All rights reserved.